Search Results - "Rybka, W B"

Refine Results
  1. 1

    PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation by Kong, Y, Zhang, J, Claxton, D F, Ehmann, W C, Rybka, W B, Zhu, L, Zeng, H, Schell, T D, Zheng, H

    Published in Blood cancer journal (New York) (31-07-2015)
    “…Prognosis of leukemia relapse post allogeneic stem cell transplantation (alloSCT) is poor and effective new treatments are urgently needed. T cells are pivotal…”
    Get full text
    Journal Article
  2. 2

    Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation by KISS, J. E, RYBKA, W. B, WINKELSTEIN, A, DEMAGALHAES-SILVERMAN, M, LISTER, J, D'ANDREA, P, BALL, E

    Published in Bone marrow transplantation (Basingstoke) (01-02-1997)
    “…We evaluated early and late hematopoietic reconstitution in 27 patients with advanced lymphoma, Hodgkin's disease, and breast or ovarian cancer after treatment…”
    Get full text
    Journal Article
  3. 3

    Human Herpesvirus 6: Infection and Disease Following Autologous and Allogeneic Bone Marrow Transplantation by Kadakia, Madhavi P., Rybka, Witold B., Stewart, John A., Patton, Joanne L., Stamey, Felicia R., Elsawy, Magdy, Pellett, Philip E., Armstrong, John A.

    Published in Blood (15-06-1996)
    “…Human herpesvirus 6 activity (HHV-6) was studied in 15 allogeneic and 11 autologous marrow transplantation patients. After transplantation, HHV-6 was isolated…”
    Get full text
    Journal Article
  4. 4

    Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period by LISTER, J, RYBKA, W. B, DONNENBERG, A. D, DEMAGALHAES-SILVERMAN, M, PINCUS, S. M, BLOOM, E. J, ELDER, E. M, BALL, E. D, WHITESIDE, T. L, LISTER, J

    Published in Clinical cancer research (01-06-1995)
    “…Relapse after high-dose chemotherapy supported by peripheral blood stem cell transplantation (HDC-PBSCT) is the main cause of therapeutic failure in patients…”
    Get full text
    Journal Article
  5. 5

    Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies by deMagalhaes-Silverman, M, Bloom, E J, Donnenberg, A, Lister, J, Pincus, S, Rybka, W B, Ball, E D

    Published in Bone marrow transplantation (Basingstoke) (01-03-1996)
    “…Between July 1991 and January 1994, 52 patients with hematologic malignancies underwent BMT using BU/CY2 as conditioning regimen. Median patient age was 38…”
    Get more information
    Journal Article
  6. 6
  7. 7

    A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation by Blostein, M D, Paltiel, O B, Thibault, A, Rybka, W B

    Published in Bone marrow transplantation (Basingstoke) (01-11-1992)
    “…Two major studies have established clinical criteria for the diagnosis of veno-occlusive disease of the liver (VOD) after bone marrow transplantation (BMT)…”
    Get more information
    Journal Article
  8. 8

    Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years by LISTER, J, SIMPSON, J. K, DEMAGALHAES-SILVERMAN, M. M, RYBKA, W. B, DONNENBERG, A. D, MYERS, D. J, BALL, E. D

    Published in Bone marrow transplantation (Basingstoke) (01-05-1997)
    “…A 32-year-old male received an allogeneic peripheral blood stem cell transplant (alloPBSCT) for myelodysplasia from his one HLA-A antigen mismatched brother…”
    Get full text
    Journal Article
  9. 9

    Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients by Memon, M, deMagalhaes-Silverman, M, Bloom, E J, Lister, J, Myers, D J, Pincus, S M, Rybka, W B, Ball, E D

    Published in Bone marrow transplantation (Basingstoke) (01-02-1995)
    “…We report the occurrence of reversible cyclosporine-induced cortical blindness in three allogeneic bone marrow transplant recipients. Possible mechanisms…”
    Get more information
    Journal Article
  10. 10

    Amplification of the graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration by Lehnert, S, Rybka, W B

    Published in Bone marrow transplantation (Basingstoke) (01-04-1994)
    “…An experimental model, previously developed to study the combined effect of partial body irradiation and the graft-versus-host (GVH) reaction, has been adapted…”
    Get more information
    Journal Article
  11. 11

    Tetraploidy in Acute Myeloid Leukemia Secondary to Large Cell Lymphoma by Kaplan, S. S., Rybka, W. B., Blom, J., Shekhter-Levin, S.

    Published in Leukemia & lymphoma (1998)
    “…A 67 year old male developed a therapy related myelodysplastic process culminating in acute myeloid leukemia 16 years following initial treatment for a large…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group by Phillips, G L, Barnett, M J, Brain, M C, Chan, K W, Huebsch, L B, Klingemann, H G, Meharchand, J, Reece, D E, Rybka, W B, Shepherd, J D

    Published in Bone marrow transplantation (Basingstoke) (01-12-1991)
    “…Between February 1988 and January 1990, 35 patients underwent allogeneic bone marrow transplantation (BMT) from unrelated donors using measures routinely…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Autologous bone marrow transplantation for adult acute leukemia by Ball, E D, Rybka, W B

    “…In this review we have considered the role of ABMT for the acute leukemias. It is apparent from data around the world that ABMT is a curative therapy for…”
    Get more information
    Journal Article
  20. 20

    High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer by DEMAGALHAES-SILVERMAN, M, RYBKA, W. B, LEMBERSKY, B, BLOOM, E. J, LISTER, J, PINCUS, S. M, VOLOSHIN, M, WILSON, J, BALL, E. D

    Published in American journal of clinical oncology (01-04-1996)
    “…This study was designed to establish the toxicity and response rates o observed with a combination of high-dose cyclophosphamide, carboplatin, and etoposide…”
    Get full text
    Journal Article